Related Experiment Video
Updated: Aug 7, 2026
14:14
Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014
A rare-cell detector for cancer
Robert T Krivacic1, Andras Ladanyi, Douglas N Curry
1Scripps-PARC Institute for Advanced Biomedical Science, Palo Alto Research Center, 3333 Coyote Hill Road, Palo Alto, CA 94304, USA.
Summary
A new fiber-optic array scanning technology (FAST) enables rapid and sensitive detection of rare cancer cells in blood. This breakthrough offers a potential solution for early cancer diagnosis and monitoring, overcoming limitations of current methods.
Area of Science:
- Oncology
- Biotechnology
- Medical Diagnostics
Background:
- Early-stage cancer detection in blood is crucial for diagnosis and monitoring but limited by current technologies' inability to detect rare cancer cells.
- Automated digital microscopy (ADM), a preferred method, is too slow for the large sample volumes required.
- Existing methods struggle with the extremely low concentrations of rare cells present in blood.
Purpose of the Study:
- To develop a faster and more sensitive method for detecting rare cancer cells in blood.
- To overcome the speed limitations of automated digital microscopy (ADM) for rare cell detection.
- To improve the specificity and sensitivity of blood-based cancer cell detection.
Main Methods:
- Implementation of fiber-optic array scanning technology (FAST) utilizing laser-printing techniques for rare-cell detection.
- FAST cytometry excites approximately 300,000 cells per second with wide-field emission collection.
- Integration of FAST enrichment with automated digital microscopy (ADM) for enhanced analysis.
Main Results:
- FAST cytometry achieves a 500-fold speed increase compared to ADM.
- The new method demonstrates comparable sensitivity and superior specificity to existing techniques.
- The combined FAST enrichment and ADM imaging approach shows high performance for early cancer detection.
Conclusions:
- Fiber-optic array scanning technology (FAST) provides a significant advancement in rare cancer cell detection from blood samples.
- The FAST-ADM combination offers the necessary performance for reliable early-stage cancer detection.
- This technology holds promise for improving cancer diagnosis and patient monitoring through blood analysis.
